Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aspirin 81 mg and pravastatin 20 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aspirin 81 mg and pravastatin 40 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aspirin 81 mg and pravastatin 80 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Butalbital 50 mg and paracetamol 325 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aspirin 325 mg and pravastatin 80 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 2,5 mg + atorvastatin 10 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aspirin 325 mg and pravastatin 40 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely amlodipine 5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 2,5 mg/atorvastatin 20 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
konjugerede østrogener, 0,3 mg + medroxyprogesteronacetat 1,5 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
abacavir 600 mg + lamivudin 300 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 5 mg + valsartan 320 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
konjugerede østrogener 0,45 mg + medroxyprogesteronacetat 1,5 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely amlodipine 10 milligram and telmisartan 80 milligram/1 each conventional release oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 2,5 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 5 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
co-proxamol 32,5 mg + 325 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 5 mg + valsartan 160 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 10 mg + valsartan 160 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
co-fluampicil 250 mg/250 mg kapsel |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 10 mg + valsartan 320 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 5 mg + benazepril 40 mg kapsel |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
acebutolol 200 mg + hydrochlorthiazid 12,5 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Choline bitartrate 25 mg and dexpanthenol 50 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amitriptylinhydrochlorid 25 mg + perphenazin 2 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amitriptylin 12,5 mg + chlordiazepoxid 10 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amitriptylinhydrochlorid 10 mg + perphenazin 2 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipinbesilat 10 mg + benazeprilhydrochlorid 20 mg kapsel |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Caffeine 25 mg and paracetamol 450 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amitriptylinhydrochlorid 25 mg + perphenazin 4 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amlodipin 2,5 mg + atorvastatin 40 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
amitriptylinhydrochlorid 50 mg + perphenazin 4 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Codeine phosphate 20 mg and ibuprofen 300 mg prolonged-release oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amobarbital sodium 100 mg and secobarbital sodium 100 mg oral capsule |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Butalbital 50 mg and paracetamol 650 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
Count of base of active ingredient |
False |
to |
Inferred relationship |
Some |
|